1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

ZBH
Zimmer Biomet Holdings, Inc.US flagNew York Stock Exchange
100.65
USD
+1.08
- -
19.47BMarket Cap

Total Valuation

Zimmer Biomet Holdings, Inc. carries a market capitalization of 19.47B, placing it among publicly traded companies globally. Its enterprise value stands at 23.48B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap19.47B
Enterprise Value23.48B

Share Statistics

Zimmer Biomet Holdings, Inc. currently has 190.56M shares outstanding.

Shares Outstanding190.56M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Zimmer Biomet Holdings, Inc. trades at a trailing price-to-earnings ratio of 20.82. The price-to-sales ratio is 1.97, and the price-to-book ratio stands at 1.30.

PE Ratio20.82
PS Ratio1.97
PB Ratio1.30
P/TBV Ratio-9.34
P/FCF Ratio8.09
P/OCF Ratio9.63

Enterprise Valuation

On an enterprise value basis, Zimmer Biomet Holdings, Inc. trades at an EV/EBITDA multiple of 9.40 and an EV/FCF ratio of 10.06. The EV/Sales ratio of 2.76 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.89 provides insight into valuation relative to core operating earnings.

EV / Sales2.76
EV / EBITDA9.40
EV / EBIT16.89
EV / FCF10.06

Financial Position

Zimmer Biomet Holdings, Inc. maintains a current ratio of 1.69, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 59.20, indicating elevated leverage, while an interest coverage ratio of 8.64 demonstrates adequate ability to service its debt obligations.

Current Ratio1.69
Quick Ratio0.72
Debt / Equity59.20
Debt / EBITDA2.99
Interest Coverage8.64

Financial Efficiency

Zimmer Biomet Holdings, Inc. posts a return on equity of 6.41 and a return on invested capital of 5.97.

Return on Equity (ROE)6.41
Return on Assets (ROA)3.53
Return on Invested Capital (ROIC)5.97
Return on Capital Employed (ROCE)5.25
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.09

Taxes

Over the trailing twelve months, Zimmer Biomet Holdings, Inc. has paid 126.60M in income taxes, reflecting an effective tax rate of 13.56.

Income Tax126.60M
Effective Tax Rate13.56

Stock Price Statistics

Zimmer Biomet Holdings, Inc.'s stock has declined approximately -2.0438% over the past 52 weeks. The 50-day moving average sits at 91.46, while the 200-day moving average is 90.90.

Beta (5Y)N/A
52-Week Price Change-2.0438%
50-Day Moving Average91.46
200-Day Moving Average90.90
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Zimmer Biomet Holdings, Inc. generated 8.51B in revenue and converted that into 806.60M in net income, yielding earnings per share of 4.12. EBITDA reached 2.50B, while operating income came in at 1.39B.

Revenue8.51B
Gross Profit5.95B
Operating Income1.39B
Pretax Income933.60M
Net Income806.60M
EBITDA2.50B
EBIT1.39B
Earnings Per Share (EPS)4.12

Balance Sheet

Zimmer Biomet Holdings, Inc. holds 410.00M in cash and equivalents against 7.48B in total debt, resulting in a net debt position of 7.07B. Total book value stands at 12.62B, with working capital of 2.08B providing operational flexibility.

Cash & Cash Equivalents410.00M
Total Debt7.48B
Net Debt7.07B
Equity (Book Value)12.62B
Book Value Per Share66.24
Working Capital2.08B

Cash Flow

Zimmer Biomet Holdings, Inc. produced 1.74B in operating cash flow over the past twelve months. After subtracting -341.50M in capital expenditures, free cash flow totaled 1.40B - equivalent to 7.19 per share.

Operating Cash Flow1.74B
Capital Expenditures-341.50M
Free Cash Flow1.40B
FCF Per Share7.19

Margins

Zimmer Biomet Holdings, Inc. operates with a gross margin of 69.87, reflecting its pricing power and cost economics. The operating margin of 16.34 and net profit margin of 9.48 provide insight into operational efficiency.

Gross Margin69.87
Operating Margin16.34
Pretax Margin10.97
Profit Margin9.48
EBITDA Margin29.36

Dividends & Yields

The company's payout ratio of 23.34 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.97
Dividend YieldN/A
Payout Ratio23.34
Shareholder Yield6.42
FCF Yield12.37

Stock Splits

Zimmer Biomet Holdings, Inc.'s most recent stock split took place on March 1, 2022 with a 100:103 split ratio.

Last Split Date3/1/2022
Split Ratio100:103

Scores

Zimmer Biomet Holdings, Inc. posts an Altman Z-Score of 4.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.81